Legal Newsline

Saturday, February 22, 2020

Ky. to receive $235K in Organon settlement

By Ashley Perry | Oct 16, 2014

Conway 150x150

FRANKFORT, Ky. (Legal Newsline) - Kentucky is part of a $31 million settlement agreement reached with drug manufacturer Organon that stems from accusations of Medicaid fraud, Attorney General Jack Conway announced on Wednesday.

The company, which is now owned by Merck, is accused of underpaying rebates to state Medicaid programs, offering inappropriate financial perks to nursing home pharmacy companies, promoting unapproved uses for antidepressants and charging inflated fees to Medicaid.

Kentucky's share of the settlement is $347,929, of which $235,346 will go to the state's Medicaid program and $112,583 will be returned to the federal government.

The settlement is the result of two whistleblower lawsuits filed in U.S. district courts in Massachusetts and Texas.

“Drug companies that engage in illegal or fraudulent practices to sell their products will not be tolerated in Kentucky,” Conway said. “I am pleased that this settlement allows us to recover funds for our vital state Medicaid program.”

Want to get notified whenever we write about ?

Sign-up Next time we write about , we'll email you a link to the story. You may edit your settings or unsubscribe at any time.